These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 14659485)
1. Experimental and modelistic approach to explain granulate inhomogeneity through preferential growth. van den Dries K; Vromans H Eur J Pharm Sci; 2003 Dec; 20(4-5):409-17. PubMed ID: 14659485 [TBL] [Abstract][Full Text] [Related]
2. Relationship between inhomogeneity phenomena and granule growth mechanisms in a high-shear mixer. van den Dries K; Vromans H Int J Pharm; 2002 Oct; 247(1-2):167-77. PubMed ID: 12429495 [TBL] [Abstract][Full Text] [Related]
3. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation. Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773 [TBL] [Abstract][Full Text] [Related]
4. A priori performance prediction in pharmaceutical wet granulation: testing the applicability of the nucleation regime map to a formulation with a broad size distribution and dry binder addition. Kayrak-Talay D; Litster JD Int J Pharm; 2011 Oct; 418(2):254-64. PubMed ID: 21530625 [TBL] [Abstract][Full Text] [Related]
5. Melt granulation in fluidized bed: a comparative study of spray-on versus in situ procedure. Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Srčič S Drug Dev Ind Pharm; 2014 Jan; 40(1):23-32. PubMed ID: 23294368 [TBL] [Abstract][Full Text] [Related]
6. Extrusion granulation and high shear granulation of different grades of lactose and highly dosed drugs: a comparative study. Keleb EI; Vermeire A; Vervaet C; Remon JP Drug Dev Ind Pharm; 2004 Jul; 30(6):679-91. PubMed ID: 15285342 [TBL] [Abstract][Full Text] [Related]
7. Combining formulation and process aspects for optimizing the high-shear wet granulation of common drugs. Cavinato M; Andreato E; Bresciani M; Pignatone I; Bellazzi G; Franceschinis E; Realdon N; Canu P; Santomaso AC Int J Pharm; 2011 Sep; 416(1):229-41. PubMed ID: 21763764 [TBL] [Abstract][Full Text] [Related]
8. The use of Stokes deformation number as a predictive tool for material exchange behaviour of granules in the 'equilibrium phase' in high shear granulation. Bouwman AM; Visser MR; Meesters GM; Frijlink HW Int J Pharm; 2006 Aug; 318(1-2):78-85. PubMed ID: 16713144 [TBL] [Abstract][Full Text] [Related]
9. Granulation of acetaminophen by a rotating fluidized-bed granulator. Kawaguchi T; Sunada H; Yonezawa Y; Danjo K; Hasegawa M; Makino T; Sakamoto H; Fujita K; Tanino T; Kokubo H Pharm Dev Technol; 2000; 5(2):141-51. PubMed ID: 10810744 [TBL] [Abstract][Full Text] [Related]
10. Drug distribution in wet granulation: foam versus spray. Tan MX; Nguyen TH; Hapgood KP Drug Dev Ind Pharm; 2013 Sep; 39(9):1389-400. PubMed ID: 23057532 [TBL] [Abstract][Full Text] [Related]
11. Granule formation and structure from single drop impact on heterogeneous powder beds. Gao T; Singaravelu ASS; Oka S; Ramachandran R; Štepánek F; Chawla N; Emady HN Int J Pharm; 2018 Dec; 552(1-2):56-66. PubMed ID: 30236649 [TBL] [Abstract][Full Text] [Related]
12. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content. Shalash AO; Molokhia AM; Elsayed MM Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831 [TBL] [Abstract][Full Text] [Related]
14. Fluid bed agglomeration with a narrow droplet size distribution. Schaafsma SH; Vonk P; Kossen NW Int J Pharm; 2000 Jan; 193(2):175-87. PubMed ID: 10606780 [TBL] [Abstract][Full Text] [Related]
15. The consequences of granulate heterogeneity towards breakage and attrition upon fluid-bed drying. Nieuwmeyer F; van der Voort Maarschalk K; Vromans H Eur J Pharm Biopharm; 2008 Sep; 70(1):402-8. PubMed ID: 18440211 [TBL] [Abstract][Full Text] [Related]
16. Effects of powder particle size and binder viscosity on intergranular and intragranular particle size heterogeneity during high shear granulation. Schaefer T; Johnsen D; Johansen A Eur J Pharm Sci; 2004 Mar; 21(4):525-31. PubMed ID: 14998584 [TBL] [Abstract][Full Text] [Related]
17. Crosslinking of drug-alginate granules. Part 2. Effect of granule preparation and composition on granule properties. Mukhopadhyay D; Saville D; Tucker IG Int J Pharm; 2008 May; 356(1-2):193-9. PubMed ID: 18337028 [TBL] [Abstract][Full Text] [Related]
18. Anomalies in some properties of powder mixtures. Varthalis S; Pilpel N J Pharm Pharmacol; 1976 May; 28(5):415-9. PubMed ID: 6749 [TBL] [Abstract][Full Text] [Related]
19. Foam granulation: new developments in pharmaceutical solid oral dosage forms using twin screw extrusion machinery. Thompson MR; Weatherley S; Pukadyil RN; Sheskey PJ Drug Dev Ind Pharm; 2012 Jul; 38(7):771-84. PubMed ID: 22085462 [TBL] [Abstract][Full Text] [Related]
20. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation. Vanhoorne V; Bekaert B; Peeters E; De Beer T; Remon JP; Vervaet C Int J Pharm; 2016 Jun; 506(1-2):13-24. PubMed ID: 27094358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]